Patent · US Expired

Hypoglycaemic and hypolipidaemic benzamide substituted (1H-) imidazole derivatives and compositions

US4507315A · kind A · utility

6Cited by
12References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 1983
Grant dateMar 26, 1985
Priority date
Expiry dateAug 22, 2003

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D249/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Benzamide derivatives of the general formula: ##STR1## wherein A represents a divalent straight- or branched-chain alkylene group containing from 1 to 6 carbon atoms and R.sup.1 represents a halogen atom or a hydroxy, mercapto, amino, nitro, cyano, carboxy or carbamoyl group or an alkyl, fluorine-substituted alkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, alkoxycarbonyl, alkylamino, dialkylamino, alkylcarbamoyl, dialkylcarbamoyl, alkanoyl, alkanoyloxy or alkanoylamino group and m represents zero or the integer 1, 2 or 3, R.sup.2 represents a hydrogen atom or an alkyl group, R.sup.3 represents a halogen atom or a hydroxy, amino, nitro, cyano, carboxy or carbamoyl group or an alkyl, fluorine-substituted alkyl, alkoxy, alkoxycarbonyl, dialkylamino, alkylcarbamoyl or alkanoylamino group and n represents zero or the integer 1 or 2, R.sup.4 represents and alkyl radical and p represents zero or the integer 1 or 2, or a pharmaceutically acceptable salt thereof, possess useful pharmacological properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.